Trial Profile
Bromfenac ophthalmic solution for the prevention of postoperative pain in patients undergoing cataract surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2012
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary)
- Indications Ocular pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors ISTA Pharmaceuticals
- 05 Jan 2012 New trial record